TempraMed Receives Final Receipt for Prospectus and Closes Reverse Takeover Transaction of TempraMed Israel

Vancouver, British Columbia--(Newsfile Corp. - October 10, 2025) - TempraMed Technologies Ltd. (the " Company ") is pleased to announce that the Company has filed and obtained a receipt on September 29, 2025, for its final long form prospectus dated September 25, 2025 (the " Prospectus "), with the British Columbia Securities Commission and is now a reporting issuer in the Province of British Columbia, effective as of September 29, 2025. The Prospectus was filed for, among other things, the purposes of allowing the Company to satisfy listing requirements of the Canadian Securities Exchange (" CSE ") and to satisfy a closing condition of the reverse takeover of the Company by TempraMed Israel Ltd. (" TempraMed ") (the " Transaction ").

Exhibitor Data Sheet